Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 8, 2017
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
[ Wed, Nov 08th 2017
] - WOPRAI
Tue, November 7, 2017
[ Tue, Nov 07th 2017
] - WOPRAI
[ Tue, Nov 07th 2017
] - WOPRAI
[ Tue, Nov 07th 2017
] - WOPRAI
[ Tue, Nov 07th 2017
] - WOPRAI
[ Tue, Nov 07th 2017
] - WOPRAI
[ Tue, Nov 07th 2017
] - WOPRAI
[ Tue, Nov 07th 2017
] - WOPRAI
Joseph France Maintained (DOC) at Buy with Increased Target to $21 on, Nov 7th, 2017
Joseph France of Cantor Fitzgerald, Maintained "Healthpeak Properties, Inc." (DOC) at Buy with Increased Target from $20 to $21 on, Nov 7th, 2017.
Joseph has made no other calls on DOC in the last 4 months.
There are 5 other peers that have a rating on DOC. Out of the 5 peers that are also analyzing DOC, 2 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Omotayo Okusanya of "Jefferies" Maintained at Hold with Increased Target to $19 on, Friday, September 22nd, 2017
- Vikram Malhorta of "Morgan Stanley" Upgraded from Sell to Hold on, Monday, July 24th, 2017
These are the ratings of the 3 analyists that currently disagree with Joseph
- John Roberts of "Hilliard Lyons" Upgraded at Strong Buy on, Monday, November 6th, 2017
- Jordan Sadler of "Keybanc" Upgraded from Hold to Buy on, Thursday, October 12th, 2017
- Chad Vanacore of "Stifel" Maintained at Strong Buy with Decreased Target to $22 on, Wednesday, July 12th, 2017
